Publications
2024
- Pediatric Robotic Laryngeal Cleft Repair.Worden CP, Prince AC, Kirse SN, Rutter C, Hackman TG, Yarbrough WG, Zanation AM, Zdanski CJ. Otolaryngol Head Neck Surg. 2024 Mar 15; 2024 Mar 15. PMID: 38488232.
- The Toxicological Effects of e-Cigarette Use in the Upper Airway: A Scoping Review.Worden CP, Hicks KB, Hackman TG, Yarbrough WG, Kimple AJ, Farzal Z. Otolaryngol Head Neck Surg. 2024 Feb 14; 2024 Feb 14. PMID: 38353408.
- Poor oral health influences head and neck cancer patient survival: an International Head and Neck Cancer Epidemiology Consortium pooled analysis.Tasoulas J, Farquhar DR, Sheth S, Hackman T, Yarbrough WG, Agala CB, Koric A, Giraldi L, Fabianova E, Lissowska J, Świątkowska B, Vilensky M, Wünsch-Filho V, de Carvalho MB, López RVM, Holcátová I, Serraino D, Polesel J, Canova C, Richiardi L, Zevallos JP, Ness A, Pring M, Thomas SJ, Dudding T, Lee YA, Hashibe M, Boffetta P, Olshan AF, Divaris K, Amelio AL. J Natl Cancer Inst. 2024 Jan 10. PMID: 37725515.
2023
- Effect of distance of treatment center on survival for HPV-negative head and neck cancer patients.Farquhar DR, Masood MM, Lenze NR, Tasoulas J, Sheth S, Lumley C, Blumberg J, Yarbrough WG, Zevallos J, Weissler MC, Zanation AM, Hackman TG, Olshan AF. Head Neck. 2023 Dec; 2023 Sep 28. PMID: 37767817.
- Time to treatment patterns of head and neck cancer patients before and during the Covid-19 pandemic.Tasoulas J, Schrank TP, Smith BD, Agala CB, Kim S, Sheth S, Shen C, Yarbrough WG, Hackman T, Sullivan CB. Oral Oncol. 2023 Nov; 2023 Aug 23. PMID: 37625360.
- A phase 2 study of neoadjuvant chemotherapy plus durvalumab in resectable locally advanced head and neck squamous cell carcinoma.Patel SA, Gibson MK, Deal A, Sheth S, Heiling H, Johnson SM, Douglas K, Flores M, Blumberg J, Lumley C, Yarbrough WG, Shen C, Chera BS, Bauman JR, Hackman T, Weiss J. Cancer. 2023 Nov 1; 2023 Jul 3. PMID: 37395170.
- Noncanonical HPV carcinogenesis drives radiosensitization of head and neck tumors.Schrank TP, Kothari A, Weir WH, Stepp WH, Rehmani H, Liu X, Wang X, Sewell A, Li X, Tasoulas J, Kim S, Yarbrough G, Xie Y, Flamand Y, Marur S, Hayward MC, Wu D, Burtness B, Anderson KS, Baldwin AS, Yarbrough WG, Issaeva N. Proc Natl Acad Sci U S A. 2023 Aug 8; 2023 Jul 31. PMID: 37523561.
- Human Immunodeficiency Virus Is Associated With Poor Overall Survival Among Patients With Head and Neck Cancer.Salahuddin S, Cohen O, Wu M, Perez Irizarry J, Vega T, Gan G, Deng Y, Isaeva N, Prasad M, Schalper KA, Mehra S, Yarbrough WG, Emu B. Clin Infect Dis. 2023 Apr 17. PMID: 36520995.
2022
- Corrigendum to "Diagnostic accuracy of FNA to determine HPV status in HPV-associated oropharyngeal squamous cell carcinoma" [Oral Oncol. 134 (2022) 106131].Morse RT, Beaty B, Scanga L, Blumberg J, Patel S, Yarbrough WG, Lumley C, Hackman T, Shen C, Gupta GP, Chera BS. Oral Oncol. 2022 Dec; 2022 Oct 21. PMID: 36274024.
- Diagnostic accuracy of FNA to determine HPV status in HPV-associated oropharyngeal squamous cell carcinoma.Morse RT, Beaty B, Scanga L, Blumberg J, Patel S, Yarbrough WG, Lumley C, Hackman T, Shen C, Gupta GP, Chera BS. Oral Oncol. 2022 Nov; 2022 Sep 30. PMID: 36191480.
- Erratum: Exploring APOBEC3A and APOBEC3B substrate specificity and their role in HPV positive head and neck cancer.Papini C, Wang Z, Kudalkar SN, Schrank TP, Tang S, Sasaki T, Wu C, Tejada B, Ziegler SJ, Xiong Y, Issaeva N, Yarbrough WG, Anderson KS. iScience. 2022 Oct 21; 2022 Oct 7. PMID: 36248736.
- Exploring ABOBEC3A and APOBEC3B substrate specificity and their role in HPV positive head and neck cancer.Papini C, Wang Z, Kudalkar SN, Schrank TP, Tang S, Sasaki T, Wu C, Tejada B, Ziegler SJ, Xiong Y, Issaeva N, Yarbrough WG, Anderson KS. iScience. 2022 Oct 21; 2022 Sep 5. PMID: 36164654.
- Comprehensive Viral Genotyping Reveals Prognostic Viral Phylogenetic Groups in HPV16-Associated Squamous Cell Carcinoma of the Oropharynx.Schrank TP, Landess L, Stepp WH, Rehmani H, Weir WH, Lenze N, Lal A, Wu D, Kothari A, Hackman TG, Sheth S, Patel S, Jefferys SR, Issaeva N, Yarbrough WG. Mol Cancer Res. 2022 Oct 4. PMID: 35731223.
- Development of a Novel Molecular Test for Determining HPV Integration Status in HPV-Positive Oropharynx Cancers.Stepp WH, Samulski TD, Hackman TG, Issaeva N, Yarbrough WG, Schrank TP. JAMA Otolaryngol Head Neck Surg. 2022 Oct 1. PMID: 36074493.
- Direct Comparison of HPV16 Viral Genomic Integration, Copy Loss, and Structural Variants in Oropharyngeal and Uterine Cervical Cancers Reveal Distinct Relationships to E2 Disruption and Somatic Alteration.Schrank TP, Kim S, Rehmani H, Kothari A, Wu D, Yarbrough WG, Issaeva N. Cancers (Basel). 2022 Sep 16; 2022 Sep 16. PMID: 36139648.
- Tumor Cell Extrinsic Synaptogyrin 3 Expression as a Diagnostic and Prognostic Biomarker in Head and Neck Cancer.Murphy RM, Tasoulas J, Porrello A, Carper MB, Tsai YH, Coffey AR, Kumar S, Zeng PY, Schrank TP, Midkiff BR, Cohen S, Salazar AH, Hayward MC, Hayes DN, Olshan A, Gupta GP, Nichols AC, Yarbrough WG, Pecot CV, Amelio AL. Cancer Res Commun. 2022 Sep; 2022 Sep 15. PMID: 36148399.
- Activation of the CREB Coactivator CRTC2 by Aberrant Mitogen Signaling promotes oncogenic functions in HPV16 positive head and neck cancer.Carper MB, Goel S, Zhang AM, Damrauer JS, Cohen S, Zimmerman MP, Gentile GM, Parag-Sharma K, Murphy RM, Sato K, Nickel KP, Kimple RJ, Yarbrough WG, Amelio AL. Neoplasia. 2022 Jul; 2022 Apr 30. PMID: 35504112.
- NF-κB over-activation portends improved outcomes in HPV-associated head and neck cancer.Schrank TP, Prince AC, Sathe T, Wang X, Liu X, Alzhanov DT, Burtness B, Baldwin AS, Yarbrough WG, Issaeva N. Oncotarget. 2022; 2022 May 24. PMID: 35634245.
- Characteristics and outcomes associated with anxiety and depression in a head and neck cancer survivorship cohort.Lenze NR, Bensen JT, Yarbrough WG, Shuman AG. Am J Otolaryngol. 2022 May-Jun; 2022 Apr 5. PMID: 35405498.
- Socioeconomic status, access to care, risk factor patterns, and stage at diagnosis for head and neck cancer among black and white patients.Emerson MA, Farquhar DR, Lenze NR, Sheth S, Mazul AL, Zanation AM, Hackman TG, Weissler MC, Zevallos JP, Yarbrough WG, Brennan P, Abedi-Ardekani B, Olshan AF. Head Neck. 2022 Apr; 2022 Jan 19. PMID: 35044015.
- Assessing Human Papillomavirus Awareness and the Role of Oropharyngeal Squamous Cell Carcinoma Education on Improving Intention to Vaccinate.Torabi SJ, Su-Velez BM, Kasle DA, Yarbrough WG, St John M, Judson BL. Laryngoscope. 2022 Mar; 2021 Aug 12. PMID: 34383306.
- Clinical outcomes, Kadish-INSICA staging and therapeutic targeting of somatostatin receptor 2 in olfactory neuroblastoma.Lechner M, Takahashi Y, Turri-Zanoni M, Liu J, Counsell N, Hermsen M, Kaur RP, Zhao T, Ramanathan M Jr, Schartinger VH, Emanuel O, Helman S, Varghese J, Dudas J, Riechelmann H, Sprung S, Haybaeck J, Howard D, Engel NW, Stewart S, Brooks L, Pickles JC, Jacques TS, Fenton TR, Williams L, Vaz FM, O'Flynn P, Stimpson P, Wang S, Hannan SA, Unadkat S, Hughes J, Dwivedi R, Forde CT, Randhawa P, Gane S, Joseph J, Andrews PJ, Royle G, Franchi A, Maragliano R, Battocchio S, Bewicke-Copley H, Pipinikas C, Webster A, Thirlwell C, Ho D, Teschendorff A, Zhu T, Steele CD, Pillay N, Vanhaesebroeck B, Mohyeldin A, Fernandez-Miranda J, Park KW, Le QT, West RB, Saade R, Manes RP, Omay SB, Vining EM, Judson BL, Yarbrough WG, Sansovini M, Silvia N, Grassi I, Bongiovanni A, Capper D, Schüller U, Thavaraj S, Sandison A, Surda P, Hopkins C, Ferrari M, Mattavelli D, Rampinelli V, Facchetti F, Nicolai P, Bossi P, Henriquez OA, Magliocca K, Solares CA, Wise SK, Llorente JL, Patel ZM, Nayak JV, Hwang PH, Lacy PD, Woods R, O'Neill JP, Jay A, Carnell D, Forster MD, Ishii M, London NR Jr, Bell DM, Gallia GL, Castelnuovo P, Severi S, Lund VJ, Hanna EY. Eur J Cancer. 2022 Feb; 2021 Dec 31. PMID: 34980502.
- Association of self-reported financial burden with quality of life and oncologic outcomes in head and neck cancer.Lenze NR, Bensen JT, Farnan L, Sheth S, Zevallos JP, Yarbrough WG, Zanation AM. Head Neck. 2022 Feb; 2021 Nov 18. PMID: 34793605.
- A 2020 Update on Public Awareness of Head and Neck Cancers.Torabi SJ, Kasle DA, Su-Velez BM, Mehra S, Day TA, Yarbrough WG, St John M, Judson BL. Otolaryngol Head Neck Surg. 2022 Feb; 2021 Apr 13. PMID: 33845657.
2021
- Evaluation of Patient-Reported Delays and Affordability-Related Barriers to Care in Head and Neck Cancer.Lenze NR, Bensen JT, Farnan L, Sheth S, Zevallos JP, Yarbrough WG, Zanation AM. OTO Open. 2021 Oct-Dec; 2021 Dec 12. PMID: 34926976.
- A case of metastatic NUT carcinoma with prolonged response on gemcitabine and nab-paclitaxel.Patel SA, Singer B, Shen C, Zanation AM, Yarbrough WG, Weiss J. Clin Case Rep. 2021 Aug; 2021 Aug 16. PMID: 34429997.
- Prognostic impact of socioeconomic status compared to overall stage for HPV-negative head and neck squamous cell carcinoma.Lenze NR, Farquhar DR, Sheth S, Zevallos JP, Lumley C, Blumberg J, Patel S, Hackman T, Weissler MC, Yarbrough WG, Olshan AF, Zanation AM. Oral Oncol. 2021 Aug; 2021 Jun 20. PMID: 34161897.
- Genomic heterogeneity and copy number variant burden are associated with poor recurrence-free survival and 11q loss in human papillomavirus-positive squamous cell carcinoma of the oropharynx.Schrank TP, Lenze N, Landess LP, Hoyle A, Parker J, Lal A, Sheth S, Chera BS, Patel SN, Hackman TG, Major MB, Issaeva N, Yarbrough WG. Cancer. 2021 Aug 1; 2021 Apr 5. PMID: 33819343.
- Socioeconomic Status Drives Racial Disparities in HPV-negative Head and Neck Cancer Outcomes.Lenze NR, Farquhar D, Sheth S, Zevallos JP, Blumberg J, Lumley C, Patel S, Hackman T, Weissler MC, Yarbrough WG, Zanation AM, Olshan AF. Laryngoscope. 2021 Jun; 2020 Nov 10. PMID: 33170518.
- Clinical Outcomes of Patients With pT1-T2N0 Oral Tongue Squamous Cell Carcinoma.Wilson JM, Lumley C, Tan X, Shen C, Coniglio A, Weissler M, Yarbrough WG, Hackman T, Blumberg J, Zanation A, Thorp B, Patel SN, Chera BS. Am J Clin Oncol. 2021 May 1. PMID: 33710132.
2020
- Global Genome Demethylation Causes Transcription-Associated DNA Double Strand Breaks in HPV-Associated Head and Neck Cancer Cells.Hajek M, Biktasova A, Sewell A, Gary C, Cantalupo P, Anderson KS, Yarbrough WG, Issaeva N. Cancers (Basel). 2020 Dec 23; 2020 Dec 23. PMID: 33374558.
- Age and risk of recurrence in oral tongue squamous cell carcinoma: Systematic review.Lenze NR, Farquhar DR, Dorismond C, Sheth S, Zevallos JP, Blumberg J, Lumley C, Patel S, Hackman T, Weissler MC, Yarbrough WG, Olshan AF, Zanation AM. Head Neck. 2020 Dec; 2020 Sep 11. PMID: 32914472.
- Systematic review and meta-analysis of racial survival disparities among oropharyngeal cancer cases by HPV status.Stein E, Lenze NR, Yarbrough WG, Hayes DN, Mazul A, Sheth S. Head Neck. 2020 Oct; 2020 Jul 7. PMID: 32632953.
- PIK3CA Mutation in HPV-Associated OPSCC Patients Receiving Deintensified Chemoradiation.Beaty BT, Moon DH, Shen CJ, Amdur RJ, Weiss J, Grilley-Olson J, Patel S, Zanation A, Hackman TG, Thorp B, Blumberg JM, Patel SN, Weissler MC, Yarbrough WG, Sheets NC, Parker JS, Neil Hayes D, Weck KE, Ramkissoon LA, Mendenhall WM, Dagan R, Tan X, Gupta GP, Chera BS. J Natl Cancer Inst. 2020 Aug 1. PMID: 31747025.
- Applications of radiomics in precision diagnosis, prognostication and treatment planning of head and neck squamous cell carcinomas.Haider SP, Burtness B, Yarbrough WG, Payabvash S. Cancers Head Neck. 2020; 2020 May 4. PMID: 32391171.
- Adjuvant external beam radiotherapy for surgically resected, nonmetastatic anaplastic thyroid cancer.Saeed NA, Kelly JR, Deshpande HA, Bhatia AK, Burtness BA, Judson BL, Mehra S, Edwards HA, Yarbrough WG, Peter PR, Holt EH, Decker RH, Husain ZA, Park HS. Head Neck. 2020 May; 2020 Feb 3. PMID: 32011055.
- Multi-Institutional Validation of Deep Learning for Pretreatment Identification of Extranodal Extension in Head and Neck Squamous Cell Carcinoma.Kann BH, Hicks DF, Payabvash S, Mahajan A, Du J, Gupta V, Park HS, Yu JB, Yarbrough WG, Burtness BA, Husain ZA, Aneja S. J Clin Oncol. 2020 Apr 20; 2019 Dec 9. PMID: 31815574.
- Innovations in risk-stratification and treatment of Veterans with oropharynx cancer; roadmap of the 2019 Field Based Meeting.Sandulache VC, Lei YL, Heasley LE, Chang M, Amos CI, Sturgis EM, Graboyes E, Chiao EY, Rogus-Pulia N, Lewis J, Madabhushi A, Frederick MJ, Sabichi A, Ittmann M, Yarbrough WG, Chung CH, Ferrarotto R, Mai W, Skinner HD, Duvvuri U, Gerngross P, Sikora AG. Oral Oncol. 2020 Mar; 2019 Oct 22. PMID: 31648864.
2019
- The Adolescent Vaping Epidemic in the United States-How It Happened and Where We Go From Here.Farzal Z, Perry MF, Yarbrough WG, Kimple AJ. JAMA Otolaryngol Head Neck Surg. 2019 Oct 1. PMID: 31436792.
- Clinical Outcomes of Head and Neck Cancer Patients Who Undergo Resection, But Forgo Adjuvant Therapy.Loganadane G, Kann BH, Park HS, Johnson SB, Mehra S, Judson BL, Bhatia A, Belkacemi Y, Yarbrough WG, Burtness B, Husain ZA. Anticancer Res. 2019 Sep. PMID: 31519591.
- Clinical value of transoral robotic surgery: Nationwide results from the first 5 years of adoption.Li H, Torabi SJ, Park HS, Yarbrough WG, Mehra S, Choi R, Judson BL. Laryngoscope. 2019 Aug; 2018 Dec 21. PMID: 30575965.
- NSD1 mutations by HPV status in head and neck cancer: differences in survival and response to DNA-damaging agents.Pan C, Izreig S, Yarbrough WG, Issaeva N. Cancers Head Neck. 2019; 2019 Jul 8. PMID: 31321084.
- Combined Aurora Kinase A (AURKA) and WEE1 Inhibition Demonstrates Synergistic Antitumor Effect in Squamous Cell Carcinoma of the Head and Neck.Lee JW, Parameswaran J, Sandoval-Schaefer T, Eoh KJ, Yang DH, Zhu F, Mehra R, Sharma R, Gaffney SG, Perry EB, Townsend JP, Serebriiskii IG, Golemis EA, Issaeva N, Yarbrough WG, Koo JS, Burtness B. Clin Cancer Res. 2019 Jun 1; 2019 Feb 12. PMID: 30755439.
- APOBEC-induced mutations and their cancer effect size in head and neck squamous cell carcinoma.Cannataro VL, Gaffney SG, Sasaki T, Issaeva N, Grewal NKS, Grandis JR, Yarbrough WG, Burtness B, Anderson KS, Townsend JP. Oncogene. 2019 May; 2019 Jan 15. PMID: 30647454.
- A Clinical Care Pathway to Reduce ICU Usage in Head and Neck Microvascular Reconstruction.Morse E, Henderson C, Carafeno T, Dibble J, Longley P, Chan E, Judson B, Yarbrough WG, Sasaki C, Mehra S. Otolaryngol Head Neck Surg. 2019 May; 2018 Jul 31. PMID: 30060705.
- Adjuvant Chemotherapy Is Associated With Improved Survival for Late-Stage Salivary Squamous Cell Carcinoma.Cheraghlou S, Schettino A, Zogg CK, Otremba MD, Bhatia A, Park HS, Osborn HA, Mehra S, Yarbrough WG, Judson BL. Laryngoscope. 2019 Apr; 2018 Aug 27. PMID: 30151947.
- HPV status in unknown primary head and neck cancer: Prognosis and treatment outcomes.Cheraghlou S, Torabi SJ, Husain ZA, Otremba MD, Osborn HA, Mehra S, Yarbrough WG, Burtness BA, Judson BL. Laryngoscope. 2019 Mar; 2018 Aug 27. PMID: 30151832.
- Genomic landscape of a metastatic malignant proliferating tricholemmal tumor and its response to PI3K inhibition.Gallant JN, Sewell A, Almodovar K, Wang Q, Dahlman KB, Abramson RG, Kapp ME, Brown BT, Boyd KL, Gilbert J, Cohen DN, Yarbrough WG, Zhao Z, Lovly CM. NPJ Precis Oncol. 2019; 2019 Feb 15. PMID: 30793038.
2018
- HPV-driven oropharyngeal cancer: current knowledge of molecular biology and mechanisms of carcinogenesis.Pan C, Issaeva N, Yarbrough WG. Cancers Head Neck. 2018; 2018 Dec 29. PMID: 31093365.
- Treatment Delays in Primarily Resected Oropharyngeal Squamous Cell Carcinoma: National Benchmarks and Survival Associations.Morse E, Judson B, Husain Z, Burtness B, Yarbrough WG, Sasaki C, Cheraghlou S, Mehra S. Otolaryngol Head Neck Surg. 2018 Dec; 2018 Jul 31. PMID: 30060700.
- Genomic and Transcriptomic Characterization Links Cell Lines with Aggressive Head and Neck Cancers.Cheng H, Yang X, Si H, Saleh AD, Xiao W, Coupar J, Gollin SM, Ferris RL, Issaeva N, Yarbrough WG, Prince ME, Carey TE, Van Waes C, Chen Z. Cell Rep. 2018 Oct 30. PMID: 30380422.
- Pretreatment Identification of Head and Neck Cancer Nodal Metastasis and Extranodal Extension Using Deep Learning Neural Networks.Kann BH, Aneja S, Loganadane GV, Kelly JR, Smith SM, Decker RH, Yu JB, Park HS, Yarbrough WG, Malhotra A, Burtness BA, Husain ZA. Sci Rep. 2018 Sep 19; 2018 Sep 19. PMID: 30232350.
- Attenuated TRAF3 Fosters Activation of Alternative NF-κB and Reduced Expression of Antiviral Interferon, TP53, and RB to Promote HPV-Positive Head and Neck Cancers.Zhang J, Chen T, Yang X, Cheng H, Späth SS, Clavijo PE, Chen J, Silvin C, Issaeva N, Su X, Yarbrough WG, Annunziata CM, Chen Z, Van Waes C. Cancer Res. 2018 Aug 15; 2018 Jun 19. PMID: 29921694.
- Extracapsular extension is not a significant prognostic indicator in non-squamous cancers of the major salivary glands.Cheraghlou S, Yu PK, Otremba MD, Mehra S, Yarbrough WG, Judson BL. Cancers Head Neck. 2018; 2018 Jul 3. PMID: 31093358.
- Adjuvant therapy in major salivary gland cancers: Analysis of 8580 patients in the National Cancer Database.Cheraghlou S, Kuo P, Mehra S, Agogo GO, Bhatia A, Husain ZA, Yarbrough WG, Burtness BA, Judson BL. Head Neck. 2018 Jul; 2018 May 13. PMID: 29756412.
- Advances in biomarkers and treatment strategies for HPV-associated head and neck cancer.Pan C, Yarbrough WG, Issaeva N. Oncoscience. 2018 May; 2018 Jun 25. PMID: 30035167.
- Association of Human Papillomavirus Status at Head and Neck Carcinoma Subsites With Overall Survival.Li H, Torabi SJ, Yarbrough WG, Mehra S, Osborn HA, Judson B. JAMA Otolaryngol Head Neck Surg. 2018 Jun 1. PMID: 29801040.
- Upfront surgery versus definitive chemoradiotherapy in patients with human Papillomavirus-associated oropharyngeal squamous cell cancer.Kelly JR, Park HS, An Y, Yarbrough WG, Contessa JN, Decker R, Mehra S, Judson BL, Burtness B, Husain Z. Oral Oncol. 2018 Apr; 2018 Mar 8. PMID: 29598952.
- Response.Bledsoe TJ, Park HS, Stahl JM, Yarbrough WG, Burtness BA, Decker RH, Husain ZA. J Natl Cancer Inst. 2018 Apr 1. PMID: 29121329.
- Salvage Surgery after Radiation Failure in T1/T2 Larynx Cancer: Outcomes following Total versus Conservation Surgery.Cheraghlou S, Kuo P, Mehra S, Yarbrough WG, Judson BL. Otolaryngol Head Neck Surg. 2018 Mar; 2018 Jan 2. PMID: 29292665.
- Untreated oral cavity cancer: Long-term survival and factors associated with treatment refusal.Cheraghlou S, Kuo P, Mehra S, Yarbrough WG, Judson BL. Laryngoscope. 2018 Mar; 2017 Sep 2. PMID: 28865100.
- Treatment deintensification in human papillomavirus-positive oropharynx cancer: Outcomes from the National Cancer Data Base.Cheraghlou S, Yu PK, Otremba MD, Park HS, Bhatia A, Zogg CK, Mehra S, Yarbrough WG, Judson BL. Cancer. 2018 Feb 15; 2017 Dec 15. PMID: 29243245.
2017
- Demethylation Therapy as a Targeted Treatment for Human Papillomavirus-Associated Head and Neck Cancer.Biktasova A, Hajek M, Sewell A, Gary C, Bellinger G, Deshpande HA, Bhatia A, Burtness B, Judson B, Mehra S, Yarbrough WG, Issaeva N. Clin Cancer Res. 2017 Dec 1; 2017 Sep 15. PMID: 28916527.
- Hypofractionated Radiotherapy for Patients with Early-Stage Glottic Cancer: Patterns of Care and Survival.Bledsoe TJ, Park HS, Stahl JM, Yarbrough WG, Burtness BA, Decker RH, Husain ZA. J Natl Cancer Inst. 2017 Oct 1. PMID: 28521361.
- Novel Role of the Mitochondrial Protein Fus1 in Protection from Premature Hearing Loss via Regulation of Oxidative Stress and Nutrient and Energy Sensing Pathways in the Inner Ear.Tan WJT, Song L, Graham M, Schettino A, Navaratnam D, Yarbrough WG, Santos-Sacchi J, Ivanova AV. Antioxid Redox Signal. 2017 Sep 10; 2017 Mar 9. PMID: 28135838.
- The risk of level IB nodal involvement in oropharynx cancer: Guidance for submandibular gland sparing irradiation.Lee NCJ, Kelly JR, Park HS, Yarbrough WG, Burtness BA, Husain ZA. Pract Radiat Oncol. 2017 Sep-Oct; 2017 Feb 16. PMID: 28356201.
- Treatment guidelines and patterns of care in oral cavity squamous cell carcinoma: Primary surgical resection vs. nonsurgical treatment.Fujiwara RJT, Burtness B, Husain ZA, Judson BL, Bhatia A, Sasaki CT, Yarbrough WG, Mehra S. Oral Oncol. 2017 Aug; 2017 Jun 23. PMID: 28688680.
- Comparison of Survival Outcomes Among Human Papillomavirus-Negative cT1-2 N1-2b Patients With Oropharyngeal Squamous Cell Cancer Treated With Upfront Surgery vs Definitive Chemoradiation Therapy: An Observational Study.Kelly JR, Park HS, An Y, Contessa JN, Yarbrough WG, Burtness BA, Decker R, Husain Z. JAMA Oncol. 2017 Aug 1. PMID: 28056116.
- The prognostic value of extranodal extension in human papillomavirus-associated oropharyngeal squamous cell carcinoma.An Y, Park HS, Kelly JR, Stahl JM, Yarbrough WG, Burtness BA, Contessa JN, Decker RH, Koshy M, Husain ZA. Cancer. 2017 Jul 15; 2017 Mar 21. PMID: 28323338.
- Expression Profiling of Clinical Specimens Supports the Existence of Neural Progenitor-Like Stem Cells in Basal Breast Cancers.Panaccione A, Guo Y, Yarbrough WG, Ivanov SV. Clin Breast Cancer. 2017 Jul; 2017 Jan 27. PMID: 28216417.
- TRAF3/CYLD mutations identify a distinct subset of human papillomavirus-associated head and neck squamous cell carcinoma.Hajek M, Sewell A, Kaech S, Burtness B, Yarbrough WG, Issaeva N. Cancer. 2017 May 15; 2017 Mar 13. PMID: 28295222.
- MYB fusions and CD markers as tools for authentication and purification of cancer stem cells from salivary adenoid cystic carcinoma.Panaccione A, Zhang Y, Ryan M, Moskaluk CA, Anderson KS, Yarbrough WG, Ivanov SV. Stem Cell Res. 2017 May; 2017 May 5. PMID: 28500913.
- Loss of LZAP inactivates p53 and regulates sensitivity of cells to DNA damage in a p53-dependent manner.Wamsley JJ, Gary C, Biktasova A, Hajek M, Bellinger G, Virk R, Issaeva N, Yarbrough WG. Oncogenesis. 2017 Apr 10; 2017 Apr 10. PMID: 28394357.
- Treatment delays in oral cavity squamous cell carcinoma and association with survival.Fujiwara RJ, Judson BL, Yarbrough WG, Husain Z, Mehra S. Head Neck. 2017 Apr; 2017 Feb 25. PMID: 28236349.
- Randomized, placebo-controlled window trial of EGFR, Src, or combined blockade in head and neck cancer.Bauman JE, Duvvuri U, Gooding WE, Rath TJ, Gross ND, Song J, Jimeno A, Yarbrough WG, Johnson FM, Wang L, Chiosea S, Sen M, Kass J, Johnson JT, Ferris RL, Kim S, Hirsch FR, Ellison K, Flaherty JT, Mills GB, Grandis JR. JCI Insight. 2017 Mar 23; 2017 Mar 23. PMID: 28352657.
- Chromosomal abnormalities and molecular landscape of metastasizing mucinous salivary adenocarcinoma.Panaccione A, Zhang Y, Mi Y, Mitani Y, Yan G, Prasad ML, McDonald WH, El-Naggar AK, Yarbrough WG, Ivanov SV. Oral Oncol. 2017 Mar; 2017 Jan 9. PMID: 28249646.
- LZAP is a novel Wip1 binding partner and positive regulator of its phosphatase activity in vitro.Wamsley JJ, Issaeva N, An H, Lu X, Donehower LA, Yarbrough WG. Cell Cycle. 2017 Jan 17; 2016 Dec 27. PMID: 28027003.
2016
- Proposing prognostic thresholds for lymph node yield in clinically lymph node-negative and lymph node-positive cancers of the oral cavity.Kuo P, Mehra S, Sosa JA, Roman SA, Husain ZA, Burtness BA, Tate JP, Yarbrough WG, Judson BL. Cancer. 2016 Dec 1; 2016 Aug 1. PMID: 27479645.
- LIM-Only Protein 4 (LMO4) and LIM Domain Binding Protein 1 (LDB1) Promote Growth and Metastasis of Human Head and Neck Cancer (LMO4 and LDB1 in Head and Neck Cancer).Simonik EA, Cai Y, Kimmelshue KN, Brantley-Sieders DM, Loomans HA, Andl CD, Westlake GM, Youngblood VM, Chen J, Yarbrough WG, Brown BT, Nagarajan L, Brandt SJ. PLoS One. 2016; 2016 Oct 25. PMID: 27780223.
- Clinical and molecular insights into adenoid cystic carcinoma: Neural crest-like stemness as a target.Yarbrough WG, Panaccione A, Chang MT, Ivanov SV. Laryngoscope Investig Otolaryngol. 2016 Aug; 2016 Aug 4. PMID: 28894804.
- Pretreatment predictors of adjuvant chemoradiation in patients receiving transoral robotic surgery for squamous cell carcinoma of the oropharynx: a case control study.Subramanian HE, Park HS, Barbieri A, Mahajan A, Judson BL, Mehra S, Yarbrough WG, Burtness BA, Husain ZA. Cancers Head Neck. 2016; 2016 Jul 4. PMID: 31093337.
- Selective antitumor activity of roscovitine in head and neck cancer.Gary C, Hajek M, Biktasova A, Bellinger G, Yarbrough WG, Issaeva N. Oncotarget. 2016 Jun 21. PMID: 27233076.
- Treatment trends and survival effects of chemotherapy for hypopharyngeal cancer: Analysis of the National Cancer Data Base.Kuo P, Sosa JA, Burtness BA, Husain ZA, Mehra S, Roman SA, Yarbrough WG, Judson BL. Cancer. 2016 Jun 15; 2016 Mar 28. PMID: 27019213.
- NOTCH1 and SOX10 are Essential for Proliferation and Radiation Resistance of Cancer Stem-Like Cells in Adenoid Cystic Carcinoma.Panaccione A, Chang MT, Carbone BE, Guo Y, Moskaluk CA, Virk RK, Chiriboga L, Prasad ML, Judson B, Mehra S, Yarbrough WG, Ivanov SV. Clin Cancer Res. 2016 Apr 15. PMID: 27084744.
2015
- National treatment patterns in patients presenting with Stage IVC head and neck cancer: analysis of the National Cancer Database.Schwam ZG, Burtness B, Yarbrough WG, Mehra S, Husain Z, Judson BL. Cancer Med. 2015 Dec; 2015 Oct 16. PMID: 26471244.
- Mitochondria, calcium, and tumor suppressor Fus1: At the crossroad of cancer, inflammation, and autoimmunity.Uzhachenko R, Shanker A, Yarbrough WG, Ivanova AV. Oncotarget. 2015 Aug 28. PMID: 26246474.
- Detection and genotype of high-risk human papillomavirus in fine-needle aspirates of patients with metastatic squamous cell carcinoma is helpful in determining tumor origin.Baldassarri R, Aronberg R, Levi AW, Yarbrough WG, Kowalski D, Chhieng D. Am J Clin Pathol. 2015 May. PMID: 25873503.
- Lymphatic drainage patterns in oral squamous cell carcinoma: findings of the ACOSOG Z0360 (Alliance) study.Farmer RW, McCall L, Civantos FJ, Myers JN, Yarbrough WG, Murphy B, O'Leary M, Zitsch R, Siegel BA. Otolaryngol Head Neck Surg. 2015 Apr; 2015 Mar 6. PMID: 25749001.
- Cellular oxidative stress response mediates radiosensitivity in Fus1-deficient mice.Yazlovitskaya EM, Voziyan PA, Manavalan T, Yarbrough WG, Ivanova AV. Cell Death Dis. 2015 Feb 19; 2015 Feb 19. PMID: 25695605.
- Negative regulation of RelA phosphorylation: emerging players and their roles in cancer.Lu X, Yarbrough WG. Cytokine Growth Factor Rev. 2015 Feb; 2014 Oct 2. PMID: 25438737.
- Esophageal perforation caused by edible foreign bodies: a systematic review of the literature.Aronberg RM, Punekar SR, Adam SI, Judson BL, Mehra S, Yarbrough WG. Laryngoscope. 2015 Feb; 2014 Aug 22. PMID: 25155167.
2014
- A tool to determine financial impact of adverse events in health care: healthcare quality calculator.Yarbrough WG, Sewell A, Tickle E, Rhinehardt E, Harkleroad R, Bennett M, Johnson D, Wen L, Pfeiffer M, Benegas M, Morath J. J Patient Saf. 2014 Dec. PMID: 24080720.
- Trends and variations in the use of adjuvant therapy for patients with head and neck cancer.Chen MM, Roman SA, Yarbrough WG, Burtness BA, Sosa JA, Judson BL. Cancer. 2014 Nov 1; 2014 Jul 15. PMID: 25042524.
- Characterization of HPV and host genome interactions in primary head and neck cancers.Parfenov M, Pedamallu CS, Gehlenborg N, Freeman SS, Danilova L, Bristow CA, Lee S, Hadjipanayis AG, Ivanova EV, Wilkerson MD, Protopopov A, Yang L, Seth S, Song X, Tang J, Ren X, Zhang J, Pantazi A, Santoso N, Xu AW, Mahadeshwar H, Wheeler DA, Haddad RI, Jung J, Ojesina AI, Issaeva N, Yarbrough WG, Hayes DN, Grandis JR, El-Naggar AK, Meyerson M, Park PJ, Chin L, Seidman JG, Hammerman PS, Kucherlapati R. Proc Natl Acad Sci U S A. 2014 Oct 28; 2014 Oct 13. PMID: 25313082.
- Hypopharyngeal cancer incidence, treatment, and survival: temporal trends in the United States.Kuo P, Chen MM, Decker RH, Yarbrough WG, Judson BL. Laryngoscope. 2014 Sep. PMID: 25295351.
- Functional kinomics identifies candidate therapeutic targets in head and neck cancer.Moser R, Xu C, Kao M, Annis J, Lerma LA, Schaupp CM, Gurley KE, Jang IS, Biktasova A, Yarbrough WG, Margolin AA, Grandori C, Kemp CJ, Méndez E. Clin Cancer Res. 2014 Aug 15. PMID: 25125259.
- Public awareness of head and neck cancers: a cross-sectional survey.Luryi AL, Yarbrough WG, Niccolai LM, Roser S, Reed SG, Nathan CA, Moore MG, Day T, Judson BL. JAMA Otolaryngol Head Neck Surg. 2014 Jul. PMID: 24902640.
- Conclusions about human papillomavirus-related malignancies.Yarbrough WG, Rosenthal E. Head Neck. 2014 Jun; 2013 Sep 2. PMID: 23696473.
- PPM1A is a RelA phosphatase with tumor suppressor-like activity.Lu X, An H, Jin R, Zou M, Guo Y, Su PF, Liu D, Shyr Y, Yarbrough WG. Oncogene. 2014 May 29; 2013 Jul 1. PMID: 23812431.
- Reverse-phase protein array profiling of oropharyngeal cancer and significance of PIK3CA mutations in HPV-associated head and neck cancer.Sewell A, Brown B, Biktasova A, Mills GB, Lu Y, Tyson DR, Issaeva N, Yarbrough WG. Clin Cancer Res. 2014 May 1; 2014 Mar 5. PMID: 24599934.